# Canine Liver Anatomy and Lobular Structure


## Key Takeaways

- The canine liver is divided into six distinct lobes: left lateral, left medial, quadrate, right medial, right lateral, and the caudate lobe (with papillary and caudate processes), supported by peritoneal attachments including the falciform, coronary, triangular, and hepatorenal ligaments.
- A dual blood supply from the hepatic artery (20-25% oxygenated) and the portal vein (75-80% nutrient-rich, partially deoxygenated) dictates the liver's unique metabolic processing capabilities before systemic circulation.
- The functional unit of the liver is the hepatic lobule, characterized by a central vein and portal triads, with hepatocytes organized into metabolic zones (periportal, midzonal, centrilobular) that influence susceptibility to toxins and hypoxia.
- Ultrasonography is the primary imaging modality for assessing liver size, echogenicity (compared to spleen and renal cortex), and parenchymal texture, with hyperechogenicity suggesting steroid hepatopathy, lipidosis, fibrosis, or neoplasia.
- Hepatic failure modes include portal hypertension (diagnosed via Doppler flow assessment), hepatic encephalopathy (indicated by elevated ammonia and bile acids), and coagulopathy (manifested by prolonged prothrombin time due to reduced factor synthesis).
- Biopsy is crucial for definitive diagnosis of diffuse disease, fibrosis, or neoplasia, with ultrasound-guided sampling or surgical biopsy recommended, and coagulation status must be assessed pre-procedure.

---

This reference article provides a structured overview of the canine liver for veterinary students and practitioners. It covers the gross anatomical organization of the organ, including its lobes, peritoneal attachments, and vascular supply, followed by the microscopic architecture of the hepatic lobule and the functional implications of its zonal organization. The content is intended to support dissection preparation, diagnostic imaging interpretation, and the pathophysiological reasoning required for clinical hepatology.

The liver is the largest glandular organ in the dog and occupies a substantial portion of the cranial abdomen, lying immediately caudal to the diaphragm. Its position, color, and texture are familiar to any clinician who has performed an abdominal exploratory, yet the precise arrangement of its lobes and the functional anatomy of its microcirculation are frequently underappreciated. A working knowledge of both scales of organization is necessary to interpret ultrasonographic findings, plan surgical biopsies, and understand the distribution patterns of hepatic disease.

## At a Glance

| Parameter | Detail |
|---|---|
| Organ location | Cranial abdomen, caudal to the diaphragm, surrounding the caudal vena cava and portal vein |
| Lobes | Six: left lateral, left medial, quadrate, right medial, right lateral, caudate (with papillary and caudate processes) |
| Peritoneal attachments | Falciform, coronary, triangular (left and right), and hepatorenal ligaments |
| Dual blood supply | Hepatic artery (oxygenated) and portal vein (nutrient-rich, partially deoxygenated) |
| Venous drainage | Hepatic veins into the caudal vena cava |
| Biliary drainage | Intrahepatic bile ducts converge to form the common bile duct, which enters the duodenum at the major duodenal papilla |
| Functional unit | Hepatic lobule (classic), portal lobule, and hepatic acinus (Rappaport) |
| Key metabolic zones | Periportal (zone 1), midzonal (zone 2), centrilobular (zone 3) |

## Gross Anatomy

### Lobes and Surfaces

The canine liver is divided into six lobes by deep fissures. The left lateral lobe is the largest, followed by the left medial lobe. The right side of the organ is composed of the right lateral and right medial lobes, with the gallbladder nestled between the right medial and quadrate lobes on the visceral surface. The caudate lobe lies dorsally and is distinguished by two processes: the caudate process, which contacts the right kidney, and the papillary process, which extends toward the lesser curvature of the stomach. The quadrate lobe is small and sits between the gallbladder and the left medial lobe.

The parietal surface is convex and moulded to the diaphragm. The visceral surface is concave and related to the stomach, duodenum, pancreas, and right kidney. The porta hepatis, located on the visceral surface, is the hilus through which the portal vein, hepatic artery, and hepatic nerves enter and the common bile duct and lymphatic vessels exit.

### Peritoneal Attachments

The liver is invested by peritoneum except at the bare area, where it contacts the diaphragm directly. The falciform ligament attaches the liver to the ventral abdominal wall and contains the round ligament, a remnant of the umbilical vein. The coronary ligament anchors the liver to the diaphragm, and the right and left triangular ligaments reinforce this attachment laterally. The hepatorenal ligament connects the caudate lobe to the right kidney. These ligaments are clinically relevant because they provide surgical landmarks and are sites where neoplastic or inflammatory processes may extend.

## Vascular Supply and Biliary Drainage

The liver receives a dual blood supply. The hepatic artery, a branch of the celiac artery, delivers oxygenated blood and supplies approximately 20 to 25 percent of the hepatic blood flow. The portal vein, formed by the confluence of the cranial and caudal mesenteric veins and the splenic vein, delivers nutrient-rich blood from the gastrointestinal tract, pancreas, and spleen. Portal blood constitutes the remaining 75 to 80 percent of hepatic inflow and is partially deoxygenated. This arrangement means that the liver is uniquely positioned to process absorbed nutrients and xenobiotics before they reach the systemic circulation.

Blood flows through the hepatic sinusoids and exits via the central veins, which coalesce to form the hepatic veins. The hepatic veins empty directly into the caudal vena cava at its passage through the liver. The biliary system begins at the bile canaliculi between hepatocytes and drains through a series of intrahepatic ducts that converge at the porta hepatis to form the common bile duct. The common bile duct courses to the duodenum and enters at the major duodenal papilla, where it is surrounded by the sphincter of Oddi. The gallbladder stores and concentrates bile and communicates with the common bile duct via the cystic duct.

## Microscopic Architecture

### The Classic Hepatic Lobule

The classic hepatic lobule is a hexagonal structure centerd on a central vein. Portal triads, containing a branch of the hepatic artery, a branch of the portal vein, and a bile ductule, are located at the corners of the hexagon. Hepatocyte plates radiate outward from the central vein, and between these plates lie the hepatic sinusoids. The sinusoids are lined by fenestrated endothelial cells and hepatic macrophages, known as Kupffer cells. The space of Disse lies between the endothelium and the hepatocytes and contains hepatic stellate cells, which store vitamin A and are central to fibrogenesis in chronic liver disease.

Blood flows from the portal triads toward the central vein, creating gradients of oxygen, nutrients, and hormones along the sinusoid. This zonation has profound metabolic consequences. Periportal hepatocytes (zone 1) receive the most oxygenated blood and are enriched for oxidative metabolism, gluconeogenesis, urea synthesis, and bile acid uptake. Centrilobular hepatocytes (zone 3) receive the least oxygenated blood and are enriched for glycolysis, lipogenesis, and biotransformation by cytochrome P450 enzymes. This explains the characteriztic centrilobular pattern of necrosis seen with many hepatotoxins, since zone 3 hepatocytes are both less protected from hypoxia and more active in generating reactive metabolites.

### The Hepatic Acinus

The hepatic acinus, described by Rappaport, is an alternative functional unit defined by blood flow instead of by anatomical boundaries. It is a diamond-shaped mass of parenchyma supplied by a terminal portal venule and a terminal hepatic arteriole. The acinus is divided into three zones based on distance from the afferent blood supply. Zone 1 is closest to the portal inflow, zone 3 is closest to the central vein, and zone 2 is intermediate. The acinar model is more useful than the classic lobule for explaining the distribution of metabolic function and toxic injury, because it is based on the actual direction of blood flow and the resulting oxygen and substrate gradients.

The distinction between the lobular and acinar models is also academic. It underpins the interpretation of biopsy findings and the prediction of which hepatic regions are vulnerable to particular insults. Hypoxic injury, for example, affects zone 3 first because this zone is farthest from the oxygen-rich portal inflow. Conversely, toxins that require bioactivation by zone 3 enzymes produce centrilobular necrosis, while toxins that are directly hepatotoxic may produce periportal injury. The [MSD Veterinary Manual professional reference](https://www.msdvetmanual.com/) provides clinical descriptions of these injury patterns in the context of canine hepatic disease.

## Functional Correlates of Structure

The structural organization of the liver directly determines its functional capacity. The fenestrated sinusoidal endothelium permits free exchange of macromolecules between blood and hepatocytes, while the space of Disse provides a compartment for the hepatic stellate cells to survey and respond to injury. The biliary polarity of hepatocytes, with canalicular domains on their lateral surfaces, allows vectorial transport of bile constituents from blood to bile. Disruption of this polarity, as occurs in cholestatic disease, leads to accumulation of bile acids and bilirubin in hepatocytes and systemic circulation.

The liver's regenerative capacity is remarkable. Following partial hepatectomy, the remaining hepatocytes re-enter the cell cycle and restore the original mass within weeks. This regeneration is orchestrated by a complex network of cytokines, growth factors, and metabolic signals. The anatomical integrity of the vascular and biliary trees is preserved during regeneration, which is a testament to the precise coordination of proliferation and tissue remodelling. Understanding these structural and functional relationships is essential for interpreting the clinical signs, laboratory abnormalities, and imaging findings that characterize canine hepatobiliary disease.

## Applied Assessment of Canine Liver Structure

### Palpation and Percussion

Hepatic palpation in the dog is performed with the animal standing or in lateral recumbency. The normal liver lies almost entirely within the costal arch, so the caudal liver edge is usually not palpable in a healthy dog. The cranial pole of the right kidney may be palpable in thin dogs and should not be mistaken for the caudate process of the caudate lobe. When the liver is enlarged, the caudal margin of the right lateral lobe can be felt as a smooth, firm edge just caudal to the last rib on the right side. Hepatomegaly from diffuse infiltration, such as lymphoma or corticosteroid-induced hepatopathy, produces a rounded, sometimes nodular edge. A distinctly irregular or knobbly margin raises suspicion for nodular hyperplasia, primary or metastatic neoplasia, or cirrhosis with regenerative nodules.

Percussion is of limited value in the dog because the liver is acoustically shielded by the lung and rib cage. Dullness extending caudal to the costal arch on the right side, however, supports hepatomegaly when combined with palpation. The technique is more useful in thin-chested breeds where the liver edge lies closer to the body wall. Neither palpation nor percussion can distinguish diffuse hepatomegaly from a mass lesion, so imaging is required for further characterization.

### Ultrasonographic Assessment

Ultrasonography is the first-line imaging modality for hepatic structure in dogs. A microconvex or curvilinear transducer in the 5 to 8 MHz range suits most adult dogs, higher frequencies around 10 MHz improve resolution in small breeds and puppies. The liver is examined from the subcostal window on the right and through the xiphoid window. The gallbladder serves as a consistent landmark, and the portal vein branches are identified by their echogenic walls, which distinguish them from the thinner-walled hepatic veins.

Normal hepatic parenchyma is homogeneous and isoechoic or slightly hypoechoic to the spleen. The echogenicity of the liver should be compared with the renal cortex and the spleen in the same image. A liver that is hyperechoic to the renal cortex but isoechoic to the spleen suggests steroid hepatopathy or lipidosis. A liver that is hyperechoic to both suggests fibrosis or marked vacuolar change. Nodules appear as discrete areas of altered echogenicity, but ultrasound cannot reliably differentiate benign from malignant nodules. Doppler interrogation of the portal vein and hepatic veins provides flow direction and velocity data. Reversed or attenuated portal flow supports portal hypertension, while a patent ductus venosus is identified by a shunt vessel connecting the portal vein to the caudal vena cava.

Ultrasound-guided fine-needle aspiration is performed when diffuse disease or nodules are identified. Aspiration cytology distinguishes vacuolar hepatopathy, lipidosis, and round cell infiltration such as lymphoma. Histopathology via Tru-Cut biopsy or surgical wedge biopsy is required when cytology is non-diagnostic, when fibrosis or cirrhosis is suspected, or when a mass requires architectural assessment. Coagulation testing, including prothrombin time, activated partial thromboplastin time, and platelet count, should be performed before biopsy because the liver synthesises most coagulation factors. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) provides current guidance on biopsy technique selection and pre-procedural assessment.

### Cross-Sectional Imaging

Computed tomography (CT) provides superior spatial resolution and is the preferred modality for surgical planning of hepatic masses, for evaluating the porta hepatis, and for detecting portosystemic shunts. CT angiography with intravenous contrast delineates the hepatic arterial, portal venous, and hepatic venous phases separately. This is particularly valuable for identifying congenital portosystemic shunts, where the anomalous vessel is traced from the portal vein to the systemic circulation. Magnetic resonance imaging is reserved for cases where CT is inconclusive, especially for intrahepatic shunt morphology or suspected biliary neoplasia.

The choice between ultrasound and CT depends on the clinical question. Ultrasound is faster, cheaper, and does not require general anesthesia, making it the appropriate first step for most dogs with suspected hepatic disease. CT is indicated when ultrasound findings are equivocal, when a mass requires three-dimensional vascular mapping before resection, or when a shunt is suspected but not confirmed sonographically. In dogs with ascites or marked obesity, ultrasound image quality degrades and CT may be the more reliable option.

### Laboratory Correlation with Structure

Serum biochemistry and hematology do not image the liver but provide functional context that changes the interpretation of structural findings. Alanine aminotransferase (ALT) is a cytosolic enzyme released with hepatocellular injury, and its magnitude correlates roughly with the number of hepatocytes damaged. Alkaline phosphatase (ALP) is induced by cholestasis and by glucocorticoids, so an elevated ALP with normal bilirubin in a dog with a structurally normal liver on ultrasound suggests steroid hepatopathy or microvascular dysplasia. Bilirubin elevation indicates more severe dysfunction or biliary obstruction. Hypoalbuminaemia, hypoglycemia, and low blood urea nitrogen suggest reduced hepatic synthetic capacity and are seen in chronic hepatopathy or portosystemic shunting.

Structural findings change the pretest probability of specific diagnoses. A young dog with a small liver on ultrasound, elevated bile acids, and a normal ALT is more likely to have a portosystemic shunt than primary hepatocellular disease. An older dog with a large, nodular liver and normal bile acids is more consistent with nodular hyperplasia than with cirrhosis. These patterns guide the decision to pursue advanced imaging, biopsy, or medical management. The [NCBI Bookshelf](https://www.ncbi.nlm.nih.gov/books/) collection of comparative physiology texts provides background on the metabolic zonation that underlies these laboratory patterns.

### Documentation and Reporting

Structured reporting of hepatic imaging findings should include liver size relative to the costal arch, parenchymal echogenicity compared with spleen and renal cortex, the presence and character of nodules, gallbladder wall thickness and contents, biliary duct diameter, and Doppler flow data. Measurements should be recorded in a consistent plane, and images should be labelled with the transducer orientation. For biopsy samples, the report must state the needle gauge, number of cores, and the lobe sampled, because the caudate lobe and left lateral lobe differ in their susceptibility to sampling error. The left lateral lobe is the largest and is most commonly sampled percutaneously, but the right medial lobe is more accessible surgically. A minimum of two cores is recommended for histopathology, and samples should be placed in 10% neutral buffered formalin at a ratio of at least 10 parts fixative to 1 part tissue.

| Imaging Finding | Likely Structural Correlate | Recommended Next Step |
| --- | --- | --- |
| Diffuse hyperechogenicity, normal size | Vacuolar hepatopathy, lipidosis, steroid effect | Cytology, bile acids, adrenal function testing |
| Diffuse hypoechogenicity, enlarged | Acute hepatitis, congestion, lymphoma | Coagulation panel, biopsy |
| Nodules, hyperechoic to liver | Nodular hyperplasia, adenoma, metastasis | Cytology, then biopsy if cytology non-diagnostic |
| Nodules, hypoechoic with target sign | Metastatic neoplasia, primary hepatic neoplasia | CT staging, biopsy |
| Small liver, irregular margin | Cirrhosis, chronic hepatitis | Bile acids, biopsy with coagulation assessment |
| Dilated intrahepatic bile ducts | Extrahepatic biliary obstruction | CT, exploratory laparotomy |

The reporting template should also note whether the gallbladder wall is thickened, because this finding accompanies cholecystitis or peritonitis and changes the urgency of intervention. Serial ultrasound examinations are compared against the baseline report, so the initial documentation must be sufficiently detailed to allow meaningful interval comparison. In dogs where a portosystemic shunt is suspected, the report should explicitly state whether the shunt is intrahepatic or extrahepatic, because this determines surgical approach and prognosis.

## Recognized Complications and Failure Modes

The canine liver's dual blood supply and high metabolic throughput create characteriztic failure patterns that clinicians should recognize early. Portal hypertension, hepatic encephalopathy, and coagulopathy represent the three most clinically significant hepatic failure modes in dogs.

Portal hypertension develops when intrahepatic resistance rises, most commonly from cirrhosis, congenital portosystemic shunts, or hepatic fibrosis. Early detection relies on ultrasonographic identification of diminished portal vein diameter, reduced portal flow velocity, or acquired shunting vessels. Ascites, abdominal distension, and diarrhea may accompany advanced portal hypertension. The discriminating finding on Doppler interrogation is hepatofugal flow, which confirms the diagnosis when portal pressure cannot be measured directly.

Hepatic encephalopathy results from impaired urea cycling and ammonia detoxification. Clinical signs range from subtle behavioral changes, ptyalism, and lethargy to seizures and coma. Preprandial and postprandial serum ammonia measurement, paired with bile acid stimulation testing, provides the laboratory basis for early detection. Fasting ammonia concentrations above the reference interval, or a postprandial bile acid rise beyond the laboratory's established threshold, warrant further investigation for portosystemic shunting or parenchymal dysfunction.

Coagulopathy in liver disease reflects reduced synthesis of vitamin K-dependent factors, particularly factors II, VII, IX, and X, as well as fibrinogen and antithrombin. Factor VII has the shortest half-life, so prolongation of prothrombin time often precedes changes in activated partial thromboplastin time. Buccal mucosal bleeding time and platelet count assessment complement coagulation testing, since thrombocytopenia from portal hypertension-associated splenic sequestration or reduced thrombopoietin production frequently coexists. Routine coagulation panels should be performed before any percutaneous sampling procedure in a patient with suspected hepatic disease.

| Observation | Likely cause | Discriminating check |
|---|---|---|
| Ascites with normal albumin | Portal hypertension | Doppler portal flow direction, acquired shunt identification |
| Postprandial lethargy or ptyalism | Hepatic encephalopathy | Paired fasting and postprandial ammonia and bile acids |
| Prolonged prothrombin time | Reduced factor VII synthesis | Vitamin K response trial, factor activity assay |
| Microhepatica on ultrasound | Cirrhosis | Histopathology, portal pressure estimation |
| Hyperbilirubinemia without hemolysis | Hepatobiliary obstruction or parenchymal failure | Biliary ultrasound, liver enzyme pattern |

## Common Errors in Assessment

Less experienced clinicians frequently misinterpret enzyme elevations without considering the enzyme's cellular origin and induction pattern. Alanine aminotransferase release indicates hepatocellular injury but does not quantify functional reserve. Alkaline phosphatase induction from glucocorticoid therapy, endogenous cortisol excess, or cholestasis can produce marked elevations with minimal structural damage. The corrective action is to interpret enzymes in context with functional markers, specifically albumin, bilirubin, glucose, and coagulation times.

A second common error involves sampling error in percutaneous biopsy. Focal lesions, particularly those in the right medial or caudate lobes, may be missed with blind needle biopsy. Ultrasound-guided sampling of a targeted lesion, or surgical biopsy when imaging cannot confidently guide the needle, reduces this risk. The clinician should also recognize that a single biopsy core may not represent diffuse disease when fibrosis is heterogeneous.

Students and new graduates often overlook the hepatic acinus as the functional unit when interpreting pathology. Lesions that appear periportal on lobule-based descriptions may actually reflect zone 1 injury in acinar terms. The corrective action is to correlate histopathology reports with the acinar model, since toxic and ischemic injuries have characteriztic zonal distributions that guide aetiological investigation.

## Evidence Limitations and Divergent Expert Opinion

The evidence base for canine hepatic diagnostics carries notable gaps. Histopathological interpretation suffers from inter-observer variability, particularly for inflammatory versus reactive changes, and the clinical significance of mild portal fibrosis remains contested. Expert opinion diverges on whether medical management or early surgical intervention offers superior outcomes for congenital portosystemic shunts, with some specialists favouring staged attenuation and others advocating single-stage ligation based on shunt morphology and intraoperative portal pressure measurements.

The role of mitochondrial dysfunction in canine hepatopathies is an active research area. Mitochondria are recognized as important targets for drug design in human cancer and neurodegenerative disease, and mitochondrial-targeted compounds can achieve more than 1000-fold higher mitochondrial concentration depending on membrane potentials, as described in the review of [mitochondria-targeted triphenylphosphonium-based compounds](https://pubmed.ncbi.nlm.nih.gov/28654243/). Whether these mechanisms translate to clinically useful canine hepatoprotective strategies remains unproven, and current recommendations rely on empirical supportive care instead of mitochondrial-directed therapy.

Nanotechnology applications for hepatic drug delivery, including targeted nanoparticles for hepatocellular carcinoma, are under investigation. The [review of nanomedicine challenges and perspectives](https://pubmed.ncbi.nlm.nih.gov/19142939/) notes that toxicological concerns and ethical implications accompany these approaches. Veterinary applications remain experimental, and clinicians should not extrapolate human trial data to canine patients without species-specific evidence.

## Referral and Escalation Criteria

Referral to a specialist should occur when diagnostic uncertainty persists after routine imaging and laboratory testing, when surgical intervention is contemplated for portosystemic shunts or hepatic masses, or when the patient deteriorates despite appropriate medical management. Persistent coagulopathy, refractory ascites, or recurrent encephalopathy despite dietary and medical therapy warrant specialist evaluation.

Laboratory involvement is indicated when histopathology results conflict with clinical findings, when copper quantification is required on biopsy specimens, or when unusual enzyme patterns suggest storage disease or toxic exposure. The laboratory should be consulted before sampling to confirm specimen handling requirements for trace mineral analysis.

Regulatory reporting obligations vary by jurisdiction. The [WOAH terrestrial animal health standards](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/) address notifiable diseases that may present with hepatic pathology, and the [AVMA practice resources](https://www.avma.org/resources-tools) provide guidance on professional obligations. Clinicians should verify local requirements, since reporting thresholds differ between regions and production systems.

## Frequently Asked Questions

### How Do I Distinguish a Normal Hepatic Lobular Pattern from Diffuse Micronodular Disease on Ultrasound?

Normal hepatic parenchyma is relatively homogeneous, with echogenicity similar to or slightly greater than the renal cortex and less than the splenic parenchyma. The portal vein walls produce bright linear echoes that create the appearance of a fine, regular pattern. Diffuse micronodular disease, such as cirrhosis, typically increases parenchymal echogenicity, blurs the margins of portal vein walls, and may reduce the conspicuity of the normal lobular texture. The liver margins often become rounded and the caudate lobe may appear enlarged relative to the left lateral lobe. When the echotexture is ambiguous, compare the liver to the spleen and right kidney in the same image. If the liver is hyperechoic to the spleen, parenchymal disease is likely. Ultrasound cannot reliably distinguish nodular regeneration from infiltrative neoplasia, so cytology or histopathology is required for a definitive diagnosis.

### What Should I Do When High-Frequency Ultrasound or Doppler Is Unavailable?

A low-frequency curvilinear probe, typically 3.5 to 5 MHz, remains adequate for assessing liver size, contour, and gross parenchymal heterogeneity in most dogs. Without Doppler, evaluate vascular patency indirectly by tracing vessels in B-mode and looking for abrupt termination, intraluminal echogenic material, or abnormal collateral vessels. The absence of color flow does not confirm thrombosis, and the presence of a visible anechoic lumen does not exclude it. Plain radiography adds limited but useful information: hepatomegaly displaces the gastric axis caudodorsally, and microhepatica allows the stomach to shift cranially. If portal hypertension or an intrahepatic shunt is suspected and Doppler is unavailable, refer for computed tomographic angiography instead of attempting a definitive diagnosis with incomplete equipment. Document the technical limitation in the medical record.

### How Does Canine Liver Anatomy Differ from Feline Anatomy in Ways That Matter Clinically?

The feline liver has the same six lobes as the canine liver, but the left medial lobe is proportionally smaller and the gallbladder is more deeply embedded in the quadrate lobe. Feline hepatocytes contain fewer lipid vacuoles at baseline, so the normal feline liver is not hyperechoic to the spleen, unlike in dogs. This makes the echogenicity comparison between liver and spleen less reliable as a disease indicator in cats. The feline cystic duct is shorter and wider, which contributes to a higher incidence of cholangitis ascending from the intestine. Portal vein branching patterns are similar, but the feline portal vein is smaller in absolute diameter, making Doppler interrogation more technically demanding. When extrapolating canine reference values for liver size or vascular dimensions to cats, apply species-specific published norms instead of simple scaling.

### What Minimum Record Keeping Is Required When I Document a Hepatic Ultrasound Examination?

Record the machine settings, including transducer frequency and depth, because these affect echogenicity interpretation. Describe the liver size, contour, margination, and echogenicity relative to the spleen and renal cortex. List each lobe examined and note any that were incompletely visualized. Document the gallbladder wall thickness, bile echogenicity, and the diameter of the common bile duct if measured. For each vascular structure assessed, record whether Doppler was used and the peak systolic velocity if obtained. Store representative still images and cine loops in the patient record. If a biopsy was performed, note the needle gauge, number of passes, and any complication such as hemorrhage. This level of detail allows a subsequent clinician to compare serial studies and supports medicolegal defensibility. The [AVMA practice resources](https://www.avma.org/resources-tools) provide general guidance on medical record content standards.

### How Should I Explain a Liver Biopsy Recommendation to a Client Who Is Reluctant?

Frame the biopsy as a diagnostic step that changes treatment, not as a default procedure. Explain that ultrasound findings such as diffuse hyperechogenicity or nodularity have several possible causes, including lipidosis, inflammation, fibrosis, and neoplasia, and that these conditions require different treatments. State that a biopsy carries a small risk of bleeding, and that coagulation testing is performed beforehand to reduce that risk. Offer a stepwise approach: start with fine-needle aspiration for cytology, which is lower risk but has lower diagnostic yield for fibrosis and well-differentiated hepatocellular carcinoma, then proceed to core biopsy if cytology is non-diagnostic. If the client declines biopsy, document the discussion, the recommended plan, and the alternative of empirical management with scheduled re-evaluation. The [MSD Veterinary Manual](https://www.msdvetmanual.com/) describes the indications and limitations of each sampling technique in detail.

### What Are the Cost and Resource Considerations When Staging a Canine Hepatopathy?

A minimum database includes hematology, serum biochemistry with bile acids, and urinalysis, which is inexpensive and widely available. Abdominal ultrasound adds moderate cost but is essential for detecting mass lesions, biliary obstruction, and vascular anomalies. Computed tomography angiography is substantially more expensive and may require general anesthesia, but it is the preferred method for characterizing portosystemic shunts and planning surgical resection. Histopathology adds laboratory fees and the risk of a biopsy procedure. When resources are limited, prioritize bile acid testing over advanced imaging, because a normal fasting and postprandial bile acid profile effectively excludes clinically significant hepatic dysfunction. If a hepatic mass is identified, cytology is cheaper than histopathology but cannot distinguish adenoma from well-differentiated carcinoma. Communicate these trade-offs explicitly so the client can make an informed financial decision.

## Related Clinical & Scientific Guides

* [Canine Respiratory System: Anatomy and Physiology](/knowledge/veterinary-medicine/veterinary-anatomy-physiology/canine-respiratory-system-anatomy-physiology)
* [Comparative Anatomy of the Mammalian Kidney](/knowledge/veterinary-medicine/veterinary-anatomy-physiology/comparative-anatomy-mammalian-kidney)
* [Feline Cardiopulmonary Physiology: Heart-Lung Interactions](/knowledge/veterinary-medicine/veterinary-anatomy-physiology/feline-cardiopulmonary-physiology-heart-lung-interactions)


## References and Further Reading

- [Mitochondria-Targeted Triphenylphosphonium-Based Compounds: Syntheses, Mechanisms of Action, and Therapeutic and Diagnostic Applications.](https://pubmed.ncbi.nlm.nih.gov/28654243/). 2017.
- [Nanomedicine--challenge and perspectives.](https://pubmed.ncbi.nlm.nih.gov/19142939/). 2009.
- [NCBI Bookshelf: Veterinary and Comparative Biomedical Sciences](https://www.ncbi.nlm.nih.gov/books/). NCBI Bookshelf.
- [MSD Veterinary Manual, Professional Edition](https://www.msdvetmanual.com/). MSD Veterinary Manual.
- [American Veterinary Medical Association Practice Resources](https://www.avma.org/resources-tools). American Veterinary Medical Association.
- [WOAH Terrestrial Animal Health Code](https://www.woah.org/en/what-we-do/standards/codes-and-manuals/terrestrial-code-online-access/). WOAH.

## Related Articles

- [Canine Lymphatic System: Anatomy and Function](/knowledge/veterinary-medicine/veterinary-anatomy-physiology/canine-lymphatic-system-anatomy-function)
- [Canine Respiratory System: Anatomy and Physiology](/knowledge/veterinary-medicine/veterinary-anatomy-physiology/canine-respiratory-system-anatomy-physiology)
- [Canine Spinal Cord Anatomy and Segmental Innervation](/knowledge/veterinary-medicine/veterinary-anatomy-physiology/canine-spinal-cord-anatomy-segmental-innervation)
- [Canine Endocrine System: Glands and Hormonal Regulation](/knowledge/veterinary-medicine/veterinary-anatomy-physiology/canine-endocrine-system-glands-hormonal-regulation)
- [Canine Heart Anatomy: Chambers, Valves, and Conduction System](/knowledge/veterinary-medicine/veterinary-anatomy-physiology/canine-heart-anatomy-chambers-valves-conduction-system)

> This article is educational professional reference material for veterinary audiences. It is not a substitute for veterinary diagnosis, individual clinical judgment, current product labeling, or applicable regulatory requirements.